Request a Quote

Joining the fight against COVID-19

April 23, 2020

COVID-19 Biospecimen


We all yearn to get back to our regular lives, whatever that may look like, as soon as possible. For the sick, that means reclaiming good health. For the sheltered in place, it means seeing our friends. For health care workers, first responders, grocery store employees and others who mix with the public, regular life means a sense of personal safety.

As for medical researchers? They’re doing what they always do, though many have turned their focus toward testing, treatment and prevention of COVID-19. At iSpecimen, we’re committed to helping medical researchers perform this research and development as quickly and easily as possible. In addition to continuing our normal work – connecting researchers to the human biospecimens they need – we are forming robust supply networks to meet the demand for coronavirus-related samples. We are now providing researchers with these biospecimens:

  • Remnant nasopharyngeal swabs from individuals who have been tested for COVID-19 via a gene-based PCR test, including positive and negative specimens. Thousands of these samples are available through iSpecimen’s clinical lab partners.
  • Prospective, custom research collections of blood, urine and/or other samples from patients with an active case of COVID-19 or who have recovered from the disease. These patients have a prime opportunity to give back to the health care system by donating samples for research through iSpecimen directly or through iSpecimen’s health care system partners around the country.
  • Remnant serum and plasma samples collected from patients with a known COVID-19 test result performed on a nasopharyngeal swab, either collected concurrently with the swab or at a selectable time period—days or even weeks – after the swab test.

iSpecimen is currently wait listing requests for the following:

  • Remnant serum samples that have been tested serologically for COVID-19 antibodies, whether the outcome was positive or negative.

We still have work to do (and more to report in coming days).

In the meantime, we are grateful for the commitment of everyone involved, including our employees, our health care system partners, our shipping partners, and the researchers upon whom all of our lives depend. We’ll do everything we can to help you.

Thank you, all of you, for bringing us closer regular life after COVID-19. Whatever that might look like.